Amyris to acquire menolabs for menopause wellness accelerating growth of consumer business

Emeryville, ca. , jan. 24, 2022 /prnewswire/ -- amyris, inc. (nasdaq: amrs), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its lab-to-market™ operating platform announces that it has agreed to exclusive terms to acquire the assets of menolabs, llc, a women-founded company to treat menopause symptoms, drive research for women's health and improve society's understanding of menopause.
AMRS Ratings Summary
AMRS Quant Ranking